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PREFACE
Systematic reviews of the role of omega-3 fatty acids in the prevention and
treatment of disease
This issue of the BJN provides a series of up to date systematic
reviews on the pleiotropic effects of omega-3 fatty acids in
health promotion and disease prevention. It is not yet 100
years since the studies of George and Mildred Burr provided
the first evidence for the essential nature of specific types of
fats. This was only made possible by the earlier pioneering
work of EV McColllum who demonstrated by controlled
studies that certain substances were necessary in small but
measurable quantities for normal health in rats. He named
these substances ‘fat-soluble A’ and ‘water-soluble B’, thus
initiating the alphabetical nomenclature for vitamins. His first
thoughts were that there existed one fat-soluble A and one
water-soluble B, but further work in his laboratory and else-
where soon indicated that there were numerous chemical
entities involved. The prevailing view at the time was that
fat represented mainly a source of energy and that its hydro-
phobic nature allowed energy to be concentrated better
than what was possible with starches. However, prominent
nutritionists indicated that animals could make fat from carbo-
hydrates provided energy supply was in excess and ridiculed
those that postulated other potential roles for fats. George
Burr worked with Evans at the time and contributed in estab-
lishing that the elusive vitamin E was in the unsaponifiable
fraction. Thus for a period of time Burr was drawn away
from considering fatty acids as a potential novel essential
dietary factor. In the process, they established that animals
fed on a fat-free diet composed of casein, sugar yeast, and
the unsaponifiable fraction of wheat germ and cod liver oils
developed deficiency symptoms. Evans was searching for a
new vitamin that could explain the observed skin changes,
while Burr decided to explore the saponifiable components.
This was a turning point in his path to discovery of essential
fatty acids. He left Evans’ laboratory at Berkeley moving to
Minnesota. Burr took two cages of Long Evans rats with
him. He also took Mildred Lawson who was in charge of the
rat colony. The rest is history: soon after they established a
laboratory and a rat colony, they announced (in 1929) that
unsaturated fat was essential, and in 1930 that linoleic acid,
and possibly other fatty acids, were also active in reversing
the skin changes and in restoring growth seen in rats fed
fat-free diets. Work over the following 60 years conclusively
determined the essential nature of both linoleic and a-linole-
nic acids. Yet few considered the importance of these nutrients
for human health until the past decades where the full signifi-
cance of dietary essential fatty acids has been realized consid-
ering their role in the synthesis of prostanoids and the myriad
of pleiotropic functions that relate directly and indirectly to
them. The prevailing belief was deeply rooted that fats were
only a concentrated source of calories that were easily
stored and served as carriers of fat-soluble vitamins.
This issue of the BJN provides a glimpse of how fast
this field has moved and serves to underscore the recent
realization in human nutrition that the quality of the fat
supply in terms of the parent n-6 and n-3 essential fatty
acids as well as their longer chain, more unsaturated deriva-
tives arachidonic, eicosapentaenoic and docosahexaenoic
acids plays a vital role in human health from conception
through every stage of human development, maturation
and aging. In terms of health and disease the essential
fatty acids and their derivatives interact at multiple levels,
including cell membrane composition, metabolism, signal
transduction and amplification, and gene expression. Fur-
thermore they influence cell growth and differentiation,
tissue repair, apoptosis and cell death and many physio-
logical and pathological processes including immunity and
inflammation. The observations made lead to a conclusion
that long chain polyunsaturated fatty acids (arachidonic,
eicosapentaenoic and docosahexaenoic acids) are condi-
tionally essential nutrients for adequate growth, develop-
ment and function in humans. Despite the impressive
documentation of EPA and DHA related health benefits,
the cellular and molecular mechanisms for their action are
still insufficiently understood.
The evidence systematically reviewed in this issue of the
BJN indicates that the effects of DHA and EPA are mediated,
not only by their known effects on membrane biophysical
properties and the corresponding electrophysiological corre-
lates, but also by effects on cell growth, differentiation and
functional maturation, and by modulating gene expression
during development and at all subsequent stages of human
life. Every tissue and every cell type is influenced not only
by the genetically coded DNA-proteome but also by the
dietary supply of essential fatty acids that determines how
tissues and animals adapt to changing environments. The
plasticity given by essential fatty acids is key to biological
adaptations of every type. What is also clear from the articles
herein, however, is that there remain multiple unanswered
questions, and specifically there is a lack of high-quality
population-based effectiveness trials in many areas crucial
to human development and health. With global population
ageing continuing apace and a concomitant increase in
the number of individuals suffering from chronic diseases
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including declining cognitive health, we must not delay in
our search for cost-effective solutions.
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